303 related articles for article (PubMed ID: 24763226)
1. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.
Bao YN; Cao X; Luo DH; Sun R; Peng LX; Wang L; Yan YP; Zheng LS; Xie P; Cao Y; Liang YY; Zheng FJ; Huang BJ; Xiang YQ; Lv X; Chen QY; Chen MY; Huang PY; Guo L; Mai HQ; Guo X; Zeng YX; Qian CN
Cell Cycle; 2014; 13(12):1958-69. PubMed ID: 24763226
[TBL] [Abstract][Full Text] [Related]
2. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
[TBL] [Abstract][Full Text] [Related]
3. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway.
Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D
Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025
[TBL] [Abstract][Full Text] [Related]
4. S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.
Meng DF; Sun R; Liu GY; Peng LX; Zheng LS; Xie P; Lin ST; Mei Y; Qiang YY; Li CZ; Xu L; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Guo LL; Xie DH; Shu DT; Li HF; Luo FF; Niu XT; Huang BJ; Qian CN
Oncogene; 2020 Jul; 39(30):5307-5322. PubMed ID: 32555330
[TBL] [Abstract][Full Text] [Related]
5. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
[TBL] [Abstract][Full Text] [Related]
6. Ulinastatin inhibits the metastasis of nasopharyngeal carcinoma by involving uPA/uPAR signaling.
Li CZ; Qiang YY; Liu ZJ; Zheng LS; Peng LX; Mei Y; Meng DF; Wei WW; Chen DW; Xu L; Lang YH; Xie P; Peng XS; Wang MD; Guo LL; Shu DT; Ding LY; Lin ST; Luo FF; Wang J; Li SS; Huang BJ; Chen JD; Qian CN
Drug Dev Res; 2023 Nov; 84(7):1468-1481. PubMed ID: 37534761
[TBL] [Abstract][Full Text] [Related]
7. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
[TBL] [Abstract][Full Text] [Related]
8. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
9. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
[TBL] [Abstract][Full Text] [Related]
10. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.
Qin L; Yin YT; Zheng FJ; Peng LX; Yang CF; Bao YN; Liang YY; Li XJ; Xiang YQ; Sun R; Li AH; Zou RH; Pei XQ; Huang BJ; Kang TB; Liao DF; Zeng YX; Williams BO; Qian CN
Oncotarget; 2015 Apr; 6(12):10239-52. PubMed ID: 25823923
[TBL] [Abstract][Full Text] [Related]
11. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.
Pavón MA; Arroyo-Solera I; Céspedes MV; Casanova I; León X; Mangues R
Oncotarget; 2016 Aug; 7(35):57351-57366. PubMed ID: 27385000
[TBL] [Abstract][Full Text] [Related]
12. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
13. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
Zhang T; Yin P; Zhang Z; Xu B; Che D; Dai Z; Dong C; Jiang P; Hong H; Yang Z; Zhou T; Shao J; Xu Z; Yang X; Gao G
Cell Death Dis; 2017 Jun; 8(6):e2838. PubMed ID: 28569772
[TBL] [Abstract][Full Text] [Related]
15. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB
J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728
[TBL] [Abstract][Full Text] [Related]
16. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway.
Hung WY; Lee WJ; Cheng GZ; Tsai CH; Yang YC; Lai TC; Chen JQ; Chung CL; Chang JH; Chien MH
Cell Oncol (Dordr); 2021 Oct; 44(5):1087-1103. PubMed ID: 34319576
[TBL] [Abstract][Full Text] [Related]
17. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.
Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G
J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775
[TBL] [Abstract][Full Text] [Related]
18. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS.
He F; Wei L; Luo W; Liao Z; Li B; Zhou X; Xiao X; You J; Chen Y; Zheng S; Li P; Murata M; Huang G; Zhang Z
Oncotarget; 2016 Jun; 7(24):37000-37012. PubMed ID: 27203742
[TBL] [Abstract][Full Text] [Related]
19. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
20. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β.
Zhao L; Lin L; Pan C; Shi M; Liao Y; Bin J; Liao W
Oncotarget; 2015; 6(12):9781-93. PubMed ID: 25909165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
